ACTA1 and diabetes mellitus: α-SMA is generally used to differentiate mesangial cells from other glomerular cells in STZ-induced diabetes mice, and increased α-SMA expression could be as the marker of mesangial cells phenotypic shifts from the non-activated phase to the proliferative, secretory activated phase (Niu et al., 2014).